Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis
Clinical trial NCT03428711 · COMPLETED
Trial details
- NCT number
- NCT03428711
- Sponsor
- Quovadis Associazione
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2024-12-31
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.